hydroxyurea has been researched along with phenanthrenes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DiPaolo, JA; Popescu, NC; Turnbull, D | 1 |
Atsumi, Y; Fujimori, H; Inase, A; Kanno, M; Masutani, M; Nakagama, H; Osawa, T; Sakasai, R; Saya, H; Sugihara, E; Tashiro, F; Teraoka, H; Yoshioka, K | 1 |
2 other study(ies) available for hydroxyurea and phenanthrenes
Article | Year |
---|---|
Sister chromatid exchange and chromosome aberration analysis with the use of several carcinogens and noncarcinogens.
Topics: 2-Acetylaminofluorene; 4-Nitroquinoline-1-oxide; 9,10-Dimethyl-1,2-benzanthracene; Acridines; Benzopyrenes; Carcinogens; Cell Line; Chromosome Aberrations; Chromosomes; Drug Evaluation, Preclinical; Hydroxyurea; Methylcholanthrene; Methylnitronitrosoguanidine; Phenanthrenes; Polycyclic Compounds; Pyrenes | 1977 |
The Arf/p53 protein module, which induces apoptosis, down-regulates histone H2AX to allow normal cells to survive in the presence of anti-cancer drugs.
Topics: Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Shape; Cells, Cultured; Cellular Senescence; Cisplatin; Cyclin-Dependent Kinase Inhibitor p16; DNA Damage; DNA Replication; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Histones; Humans; Hydroxyurea; Mice; Mice, Knockout; Mutation; Phenanthrenes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Tumor Suppressor Protein p53 | 2013 |